Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749098 · ClinicalTrials.gov registry record · Phase 1
A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT01749098 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 29 participants.
The verdict
NCT01749098, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
To assess if PF-04958242 can attenuate the ketamine-induced cognitive impairment in verbal learning and memory, episodic memory and spatial working memory in healthy volunteers.
Interventions
- DRUG Placebo
- DRUG Ketamine
- DRUG PF-04958242
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749098
The ClinicalTrials.gov registry entry for NCT01749098 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01749098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01749098 about?
NCT01749098 is a clinical study titled "A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers". To assess if PF-04958242 can attenuate the ketamine-induced cognitive impairment in verbal learning and memory, episodic memory and spatial working memory in healthy volunteers.
What is the current status of trial NCT01749098?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2012-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01749098?
The interventions under investigation include: Placebo (DRUG), Ketamine (DRUG), PF-04958242 (DRUG).
Who is sponsoring clinical trial NCT01749098?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.